Showing results (631-640 of 933) with videos related to

Sort By:
Pageof 94
Frontiers in Immunology|September 10, 2019
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus ChallengeMeagan McMahon, Guha Asthagiri Arunkumar, Wen-Chun Liu, et al.
Journal of Clinical Microbiology|March 7, 2001
Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a humanP G Halbur, C Kasorndorkbua, C Gilbert, et al.
Nature Medicine|July 29, 2008
Effective induction of high-titer antibodies by viral vector vaccinesSimon J Draper, Anne C Moore, Anna L Goodman, et al.
The Journal of Infectious Diseases|June 8, 2004
Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian menVasee S Moorthy, Egeruan B Imoukhuede, Sheila Keating, et al.
Chest|June 6, 2009
Structured approaches to pain management in the ICUChris Pasero, Kathleen Puntillo, Denise Li, et al.
Chest|May 8, 2009
Pain management within the palliative and end-of-life care experience in the ICURichard A Mularski, Kathleen Puntillo, Basil Varkey, et al.
The Biochemical Journal|December 16, 2016
Structure and lipid-binding properties of the kindlin-3 pleckstrin homology domainTao Ni, Antreas C Kalli, Fiona B Naughton, et al.
Vaccines|September 28, 2024
Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell VaccineEdmund G-T Wee, Sarah Kempster, Deborah Ferguson, et al.
Transplantation|September 20, 2017
Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 TrialJakob Mühlbacher, Bernd Jilma, Markus Wahrmann, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 4, 2015
HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patientsD Salmon, F Bani-Sadr, C Gilbert, et al.
Pageof 94